Literature DB >> 11798256

Risk of infection and death among post-splenectomy patients.

N Bisharat1, H Omari, I Lavi, R Raz.   

Abstract

OBJECTIVES: The true incidence of post-splenectomy sepsis remains undetermined.
METHODS: An English literature review on post-splenectomy sepsis was undertaken by means of databases of MEDLINE for the period 1966-96. The data registered included age at splenectomy, indication for splenectomy, incidence of infection and death, interval between splenectomy and infection, and microbial aetiology.
RESULTS: The reports include 19 680 patients having undergone splenectomy with a median follow up of 6.9 years. The incidence of infection after splenectomy was 3.2% and the mortality rate was 1.4%. Only 6942 reports were sufficiently detailed to allow useful analysis. The incidence of infection among children and adults was similar, 3.3% and 3.2%, respectively. However, the death rates among children were higher than adults (1.7% vs. 1.3%). The incidence of infection was highest among patients with thalassemia major (8.2%), and sickle-cell anaemia (7.3%). The highest mortality rates were observed among patients with thalassaemia major (5.1%), and sickle-cell anaemia (4.8%).
CONCLUSION: The incidence of sepsis among post-splenectomy patients is low, however, it carries a high mortality rate especially among children with hematological disorders. Copyright 2001 The British Infection Society.

Entities:  

Mesh:

Year:  2001        PMID: 11798256     DOI: 10.1053/jinf.2001.0904

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  106 in total

1.  Occurrence of overwhelming gram-negative infections in splenectomised patients with thalassaemia major.

Authors:  Mardawig Alebouyeh; Farideh Moussavi
Journal:  Eur J Pediatr       Date:  2003-06-17       Impact factor: 3.183

2.  Immune profile of asplenic patients following single or double vaccine administration: A longitudinal cross-sectional study.

Authors:  Sait Murat Doğan; Ahmet Aykas; Evrim Şefika Yücel; Gökalp Okut; Cenk Şimşek; Kürşat Çayhan; Baha Zengel; Adam Uslu
Journal:  Ulus Cerrahi Derg       Date:  2015-04-09

3.  Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study.

Authors:  Thomas Pincez; Corinne Guitton; Frédéric Gauthier; Guénolée de Lambert; Véronique Picard; Madeleine Fénéant-Thibault; Ali Turhan; Narla Mohandas; Gil Tchernia; Loïc Garçon
Journal:  Blood       Date:  2016-01-15       Impact factor: 22.113

4.  Renal transplantation in a patient with idiopathic thrombocytopenic purpura.

Authors:  Eun Mi Hwang; Hyun Young Woo; Beom Soon Choi; Chul Woo Yang; Yong Soo Kim; In Sung Moon; Byung Kee Bang
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

5.  Preventing severe infection after splenectomy.

Authors:  Adrian Newland; Drew Provan; Steven Myint
Journal:  BMJ       Date:  2005-08-20

6.  Pediatric splenectomy for hematological diseases: outcome analysis.

Authors:  C U Durakbasa; C Timur; V Sehiralti; M Mutus; N Tosyali; A Yoruk
Journal:  Pediatr Surg Int       Date:  2006-07-13       Impact factor: 1.827

7.  Vaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policies.

Authors:  L Bruni; J M Bayas; A Vilella; A Conesa
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

8.  The effect of rituximab on vaccine responses in patients with immune thrombocytopenia.

Authors:  Ishac Nazi; John G Kelton; Mark Larché; Denis P Snider; Nancy M Heddle; Mark A Crowther; Richard J Cook; Alan T Tinmouth; Joy Mangel; Donald M Arnold
Journal:  Blood       Date:  2013-07-12       Impact factor: 22.113

Review 9.  Percutaneous drainage of abdominal and pelvic abscesses in children.

Authors:  Colin Brown; Lisa Kang; Stanley T Kim
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

10.  Partial spleen resection with a radiofrequency needle device--a pilot study.

Authors:  Juliane Liese; Sven Kohler; Christian Moench; Wolf Otto Bechstein; Frank Ulrich
Journal:  Langenbecks Arch Surg       Date:  2013-02-06       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.